BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36191973)

  • 101. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
    Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study.
    Yang M; Lin SQ; Liu XY; Tang M; Hu CL; Wang ZW; Zhang Q; Zhang X; Song MM; Ruan GT; Zhang XW; Liu T; Xie HL; Zhang HY; Liu CA; Zhang KP; Li QQ; Li XR; Ge YZ; Liu YY; Chen Y; Zheng X; Shi HP
    Front Immunol; 2023; 14():1131496. PubMed ID: 37063910
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma.
    Iseda N; Itoh S; Yoshizumi T; Tomiyama T; Morinaga A; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Oda Y; Mori M
    Int J Clin Oncol; 2021 Oct; 26(10):1890-1900. PubMed ID: 34251555
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Colon inflammatory index as a useful prognostic marker after R0 resection in patients with colorectal cancer liver metastasis.
    Ishii M; Tominaga T; Nonaka T; Oyama S; Moriyama M; Maruyama K; Sawai T; Nagayasu T
    PLoS One; 2022; 17(10):e0273167. PubMed ID: 36194563
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Combined analysis of preoperative and postoperative lymphocyte-C-reactive protein ratio precisely predicts outcomes of patients with gastric cancer.
    Miyatani K; Sawata S; Makinoya M; Miyauchi W; Shimizu S; Shishido Y; Matsunaga T; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Saito H; Fujiwara Y
    BMC Cancer; 2022 Jun; 22(1):641. PubMed ID: 35690739
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The Relation Between Serum-based Systemic Inflammatory Biomarkers and Locoregional Lymph Node Metastasis in Clinical Stages I to II Right-sided Colon Cancers: The Role of Platelet-to-Lymphocyte Ratio.
    Lale A; Sahin E; Aslan A; Can OF; Ebiloglu MF; Aygen E
    Surg Laparosc Endosc Percutan Tech; 2023 Dec; 33(6):603-607. PubMed ID: 37725826
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer.
    Zhang HY; Xie HL; Ruan GT; Zhang Q; Ge YZ; Liu XY; Tang M; Song MM; Lin SQ; Yang M; Zhang XW; Xu HX; Song CH; Shi HP
    BMC Cancer; 2022 Oct; 22(1):1080. PubMed ID: 36266627
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The Association of Inflammatory Related Markers with the Prognosis in Elderly Patients with Colorectal Cancer.
    Chiang SW
    Cancer Manag Res; 2024; 16():37-48. PubMed ID: 38259607
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.
    Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Yokoe T; Saigusa S; Tanaka K; Shirai Y; Kobayashi M; Ohi M; Araki T; McMillan DC; Miki C; Goel A; Kusunoki M
    Ann Surg; 2020 Aug; 272(2):342-351. PubMed ID: 32675548
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Prognostic Impact of Lymphocyte-to-C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Pancreatic Cancer.
    Iseda N; Iguchi T; Hirose K; Itoh S; Honboh T; Sadanaga N; Matsuura H
    Am Surg; 2023 Nov; 89(11):4452-4458. PubMed ID: 35920820
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Prediction of survival in patients with colorectal liver metastases- development and validation of a prognostic score model.
    Villard C; Abdelrafee A; Habib M; Ndegwa N; Jorns C; Sparrelid E; Allard MA; Adam R
    Eur J Surg Oncol; 2022 Dec; 48(12):2432-2439. PubMed ID: 35786533
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Is C-reactive protein-albumin ratio or neutrophil-lymphocyte ratio a better indicator to predict in-hospital mortality in traumatic brain injury?
    Özeren E
    Ulus Travma Acil Cerrahi Derg; 2022 Oct; 28(10):1482-1487. PubMed ID: 36169474
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Lymphocyte-C-reactive protein ratio with calf circumference could better predict survival of patients with non-metastatic cancer.
    Liu XY; Zhang X; Zhang Q; Ruan GT; Xie HL; Liu T; Song MM; Ge YZ; Deng L; Shi HP
    Sci Rep; 2023 May; 13(1):7217. PubMed ID: 37137949
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Comprehensive Analysis of Prognostic Factors in Advanced Gastric Cancer Patients Treated with Chemotherapy.
    Cavdar E; Iriagac Y; Avci O; Seber ES
    J Coll Physicians Surg Pak; 2022 Nov; 32(11):1420-1424. PubMed ID: 36377008
    [TBL] [Abstract][Full Text] [Related]  

  • 115. The neutrophil-to-lymphocyte ratio and lactate dehydrogenase combined in predicting liver metastasis and prognosis of colorectal cancer.
    Chen Q; Li GL; Zhu HQ; Yu JD; Chen ZP; Wu JY; Lin ZY; Wan YL
    Front Med (Lausanne); 2023; 10():1205897. PubMed ID: 37425297
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients.
    Yamamoto T; Kawada K; Obama K
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360768
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Clinical impact of lymphocyte/C-reactive protein ratio on postoperative outcomes in patients with rectal cancer who underwent curative resection.
    Yamamoto T; Fukuda M; Okuchi Y; Oshimo Y; Nishikawa Y; Hisano K; Kawai T; Iguchi K; Okuda Y; Kamimura R; Tanaka E; Terajima H
    Sci Rep; 2022 Oct; 12(1):17136. PubMed ID: 36229569
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma.
    Yang Z; Zhang D; Zeng H; Fu Y; Hu Z; Pan Y; Chen J; Wang J; Zhang Y; Zhou Z; Xu L; Hu D; Chen M
    J Inflamm Res; 2022; 15():5721-5731. PubMed ID: 36238770
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Association between inflammation-based prognostic markers and mortality of non-cardiac surgery.
    Oh AR; Park J; Lee JH; Yang K; Ahn J; Lee SH; Lee SM
    Korean J Anesthesiol; 2023 Dec; 76(6):550-558. PubMed ID: 36824044
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Neutrophil-to-lymphocyte ratio as a prognostic factor for survival in patients with colorectal liver metastases: A systematic review.
    Papakonstantinou M; Fiflis S; Christodoulidis G; Giglio MC; Louri E; Mavromatidis S; Giakoustidis D; Papadopoulos VN; Giakoustidis A
    World J Clin Oncol; 2022 Oct; 13(10):822-834. PubMed ID: 36337307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.